Grant: CIHR Fellowship
Direct Payment
$150,000.00
Understanding in Detail the Abnormal State of the Transcriptome in Human Breast Cancer
FY 2010-11
Summary
Breast cancer is a global epidemic. The Canadian Cancer Society estimates that 1 in 9 Canadian women will be diagnosed with breast cancer in their lifetimes. Despite current classification systems, new research suggests that breast cancer is, in fact, numerous diseases. Next generation sequencing is revolutionary technology used to sequence and catalogue all mutations occurring during the development and progression of cancer. We will build upon Professor Stratton's existing cancer genomics research platform to sequence 1,500 breast cancer samples. Each breast cancer will be simultaneously assessed for dysfunctions in the primary genetic message (genomic mutations) and for aberrations in the way in which this message is translated into protein (transcriptomic mutations). The proposed research constitutes the largest sample set ever interrogated at this depth of analysis. The results will paint a complete portrait of breast cancer mutations and will help to untangle the complexity of breast cancer initiation and metastasis.
Department
Program
CIHR Fellowship
Recipient
Location
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
226029
Name
Shlien Adam
Country
United Kingdom
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Understanding in Detail the Abnormal State of the Transcriptome in Human Breast Cancer
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Breast Cancer; Cancer; Cancer Genomics; Genomics; Next Generation Sequencing; Rna; Rna-Seq; Sequencing; Transcription
Abstract
Breast cancer is a global epidemic. The Canadian Cancer Society estimates that 1 in 9 Canadian women will be diagnosed with breast cancer in their lifetimes. Despite current classification systems, new research suggests that breast cancer is, in fact, numerous diseases. Next generation sequencing is revolutionary technology used to sequence and catalogue all mutations occurring during the development and progression of cancer. We will build upon Professor Stratton's existing cancer genomics research platform to sequence 1,500 breast cancer samples. Each breast cancer will be simultaneously assessed for dysfunctions in the primary genetic message (genomic mutations) and for aberrations in the way in which this message is translated into protein (transcriptomic mutations). The proposed research constitutes the largest sample set ever interrogated at this depth of analysis. The results will paint a complete portrait of breast cancer mutations and will help to untangle the complexity of breast cancer initiation and metastasis.
Competitiondate
201102
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Shlien, Adam
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~